Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 1589 - файл
.pdf
Литература 161
https://t.me/med1917
257. Melton L.J. // J. Bone Miner. Res. — 1995. — V. 10. — P. 175–177.
258. Metcalf M.G., Braiden V., Livesey J. Retention of normal ovarian function
after hysterectomy // J. Endocrinol. — 1992. — V. 135. — P. 597–602.
259. Mittendorf R., Aronson M.P., Berry R.E. et al. Avoid serious infections
associated with abdominal hysterectomy: meta-analysis of antibiotic
prophylaxis // Amer. J. Obstet. Gynecol. — 1993. — P. 1119–1124.
260. Moore H.C. Managing menopause after breast cancer: balancing risk and
benefits // Clin. J. Med. — 2001. —V. 68. — № 3. — P. 243–248.
261. Morrison N.A., Qi J.S., Tokita A. et al. // Nature. — 1994. — V. 367. —
P. 284–287.
262. Nathan L., Chandhuri G. Estrogens and atherosclerosis // Ann. Rev.
Pharmacol. Toxicol. — 1997. — V. 37. — P. 477–515.
263. Nathorst-Boos J., Fuchs T., Von Schoults B. Consumers attitude to
hysterectomy. The experience of 678 women // Acta. Obstet. Gynecol.
Scand. — 1992. — V. 71. — P. 230–234.
264. Nilas L., Christiansen C. Bone mass and its relationship to age and the menopause // J. Clin. Endocrinol. Metab. — 1987. — V. 65. — P. 697–701.
265. Nilas L., Christiansen C. The pathophysiology of peri- and postmenopausal
bone loss // Brit. J. Obstet. Gynecol. — 1989. — V. 96. — P. 580–583.
266. O’Connell D., Robertson J., Henry D. et al. An assessment of the treatment
effects: a system recien of the skeletal effects of estrogen therapy in postmenopausal women // Climacteric. — 1998. — V. 1–2. — P. 112–123.
267. Palmer J.R., Rosenberg L., Clarke E.A. et al. Breast cancer risk after
estrogen replacement therapy: Results from the Toronto Breast Cancer
Study // Amer. J. Epidemiol. — 1991. — V. 134. — P. 1386–1395.
268. Palmer J.K., Rosenberg L., Shapiro S. // Amer. J. Epidemiol. — 1992. —
V. 131. — P. 408–416.
269. Panay N., Sands R.H., Studd J.W.W. The brain: source and target for sex
ste roid hormones / Ed. A.R. Genazzani., F. Petraglia., R.H. Purdy. —
The Parthenon Publishing Group, 1996. — P. 257–276.
270. Parfitt A.M. The actions of parathyroid hormone on bone. Relation to
bone remodeling and turnover, calcium homeostasis and Metabolic bone
disceases // Metabolism. — 1976. — V. 25. — P. 909–955.
271. Pasqualini I.R., Chetrite G. Контроль активности эстронсульфазы
в клетках рака молочной железы человека, влияние тиболона и его
метаболитов // Акуш. и гин. — 1998. — № 6. — С. 34–37.
272. Persson I., Weiderpass E., Bergkvist L. et al. Risks of breast endometrial
cancer after estrogen and estrogen — progestin replacement // Cancer
Causes Control. — 1999. — V. 10. — P. 253–260.
273.
Plock E. Hormonal replacement therapy in patients after cervical cancer
treatment // Gynecik. Oncol. — 1987. — V. 26. — P. 169–177.
274. Prince R.L., Dick I.M. // J. Climacteric. — 1999. — V. 2. — S. 1. — P. 42.
275. Randall C., Paloncek F. The frequency of oophorectomy at the time of hys-
terectomy // Amer. J. Obstet. Gynecol. — 1991. — V. 100. — P. 716–721.
162 Литература
https://t.me/med1917
276. Reginster J.Y., Deroisy R., Lecart M.P. Calcium and postmenopausal bone
loss // Menopausal Digest. — 1991. — № 3. — P. 5–6.
277. Reginster J.Y., Zheng J.X., Gesnen V. et al. // Osteoporosis. Int. — 1996. —
V. 6. — S. 1. — P. 106.
278. Richter K. Die operative therapie descensus und ihre wandlung // Wiener
Klin, Wschn. — 1996. — Bd. 88. — S. 733.
279. Riedel H.H., Lehmann-Willenbrock E., Semm K. Ovarian failure phenomena
after hysterectomy // J. Reprod. Med. —1986. —V. 31. — P. 597–600.
280. Riedel H.H., Lehmann-Willenbrock F. Ovarialle ausballserchein-ungen
nach hysterectomy und destruktiven eileitersterilisations verfahren //
Zend. bl. Gynakol. — 1987. — V. 109. — S.770–775.
281. Riggs B.N., Spelsberg T.C. Estrogen end bone osteoporosis-today and
in the future (mini symposium) // The 4th International Congress on
Osteoporosis. — Hong Kong, 1993. — P. 8–13.
282. Rijpkema A.H.M., Van der Sanden A.A., Ruijs A.H.C. Effects of postmenopausal estrogen-progesteron replacement therapy on serum lipids and lipoproteins: a review // Maturitas. — 1990. — V. 12. — P. 259–285.
283. Robert H. Le vecu de l’hyster
V. 31. — № 2. — P. 171–177.
284. Rosenberg L., Palmer J.R., Shapiro S. A case-control study of myocardial
infarction in relation to use of estrogen supplements // Amer. J. Epid. —
1993. — V. 137. — P. 54–63.
285. Ross D. Risk of hormone replacement therapy. — 1996. — P. 133–147.
286. Rosenbaum H. IV European Congress on Menopause, Vienna / Ed.
M. Birkhauser, H. Rosenbaum. ESKA. — Paris, 1998. — P. 13–24.
287. Russo I., Russo J. Oestrogen and cell proliferation in the human breast //
J. Cardiovascular Pharmacology. — 1996. — V. 28. — P. 19.
288. Samaan S.A., Granford M.H. Estrogen and cardiovascular function after meno-
pause // J. Amer. Coll. Cardiol. — 1995. — V. 26. — № 1465. — P. 1403–1410.
289. Sarrel P.M., Lindsay D., Rosano G. Angina and normal coronary arteries
in women gynecologie findings // Amer. J. Obstet. Gynecol. — 1992. —
V. 167. — P. 467–472.
290. Scheele F., Burger C.V., Kenemans P. Postmenopausal hormone
replacement therapy in the women with a reproductive risk faktor for
breast cancer // Maturitas. — 1999. — V. 33. — P. 191–196.
291. Skotti R.I., Bergmann R.I., Bhatia N.N. et al. Urodynamic changes in
ureterovesical function after radical hysterectomy // Obstet. Gynecol. —
1986. — V. 68. — № 1. — P. 111–120.
292. Secnil A.M. Lipoprotein as a thrombogenic factors. Thrombolysis: basis
contributions and clinical progress / Ed. E. Haber., E. Braunnald. — Book
Juk: Mosby Year, 1991. — P. 105–111.
293. Seed M., Crook D. Postmenopausal hormone replacement therapy,
coronary heart disease and plasma lipoproteins // Curr. Opinion.
Lipidol. — 1994. — V. 5. — P. 48–58.
éctomie // Gynecologie (Paris). — 1974. —
Литература 163
https://t.me/med1917
294. Siddle N., Sarrel P., Whitehead M. The effect of hysterectomy on the age at
ovarian failure: identification of a subgroup of women with premacure loss
ovarian function and literature review // Fertil. Steril. — 1986. — V. 47. —
P. 94–100.
295. Sneider H.P.A., Schmidt-Collvitzen K. A new approach in the treatment
of climacteric disorders // Ed. H.P.A. Snieder et al. — Berlin, 1992. —
P. 17–28.
296. Soura A.Z., Fonoseca A.M., Izzo V. et al. Ovarian histology and function
after total abdominal hysterectomy // Obstet. Gynecol. — 1986. —
V. 68. — № 6. — P. 847–849.
297. Sovers M.R., La Pieta M.T. Menopause: its Epidemiology and Potential
Association with chronic diseases // Epidemiol. R.W. — 1995. — V. 17. —
№ 2. — P. 141.
298. Spelsberg T.C., Waters K.M., Subramaniam M. et al. // J. Climacteric. —
1999. — V. 2. — S. 1. — P. 41.
299. Spyridopoulos I., Sullivan A.B., Klarney M. et al. // Circulation. — 1997. —
V. 95. — P. 1505–1514.
300. Staffa J.A., Newschaffer C.J., Iones J.-K. et al. Progestins and breast cancer:
An epidemiologic review // Fertil. Steril. — 1992. — V. 57. — P. 473–491.
301. Stampfer M.J., Colditz G.A. Estrogen replacement therapy and co ronary
heart disease: a quantitative assessment of the epidemiologic evidence //
Preventive Medicine. — 1991. — V. 47. — P. 47–63.
302. Stone S., Dickey R., Mickal A. The acute of hysterectomy on ova rian function // Amer. Obstet. Gynecol. — 1975. — V. 121. — P. 193–197.
303. Storm H.H., Clemmenson I.H., Manders T. et al. Supravaginal uterine ampu-
tation in Denmark // Obstet. Gynecol. — 1988. — V. 45. — P. 198–201.
304. Studd J., Khastgir G. Hormone replacement therapy after hysterectomy
The management of the menopause // Avnual Reviw / Ed. J. Studd. —
1998. — P. 257–270.
305. Sullivan J.M., Vander Zwaag R., Hughes J.P. et al. Estrogen replacement
therapy and coronary heart disease: effect on survival in postmenopausal
women // Arch. Intern. Med. — 1990. — V. 150. — P. 2557–2562.
306. The Writing Group for the PEPI Trial. Effects of estrogen — progestin
regimens heart disease risk factors in postmenopausal women //
I.A.M.A. — 1995. — V. 273. — P. 199–208.
307. Theriault R.L. Hormone replacement therapy and breast cancer: An overview // Brit. J. Obstet. Gynecol. — 1996. — V. 103. — № 13. — P. 87–91.
308. Toniolo P., Levitz M., Leleniuch-Iacguotte et al. A prospective study of
endogenous estrogens breast cancer in postmenopausal women // J. Nath.
Cancer. Iust. — 1995. — V. 87. — P. 190–197.
309. Tuohimaa P., Blauer M., Pasanen S. Mechanisms of sex steroid: hormones:
basis concepts and clinical correlations // Maturitas. — 1996. — V. 42. —
P. 3–12.
164 Литература
https://t.me/med1917
310. Vtian W.H. Effect of hysterectomy and estrogen therapy on libido // Int.
Obstet. Gynecol. — 1975. — V. 13. — P.97–102.
311. Van Leusden H.A.I.M. Заместительная гормональная терапия и рак
молочной железы // Рос. мед. журн. — 1996. — Т. 4. — № 11. — С. 6–8.
312. Velde E.R., Van Leusden H. Hormonal treatment for the climacteric
alleviation of symptoms and prevention of in postmenopausal disease //
Lancet. — 1994. — V. 343. — C. 654–658.
313. Vervest H.A., Barents J.W., Haspels A.A. et al. Radical hysterectomy and
the function of the former urinary tract. Urodynamic quantification of
changes in storage and evacuation function // Acta Obstet. Gynecol.
Scand. — 1989. — V. 68. — № 4 — P. 331–340.
314. Vessey M.P., Villard-Mackintoch L., McPherson K. et al. The epidemiology
of hysterectomy: find a large cohort study // Brit. J. Obstet. Gynecol. —
V. 93. — P. 402–407.
315. Virtanen H., Makinen J., Tenho T. et al. Effects of abdominal hysterectomy
on urinary and sexual symptoms // Brit. J. Urol. — 1993. — V. 72. —
№ 6. — P. 868–872.
316. Wagner J.D., Clarkson T.B., Clair R.W. et al. Estrogen and progesterone
replacement therapy reduces for density lipoprotein accumulation in
the coronary arteries of surgically postmenopausal monkeys // J. Clin.
Invest. — 1991. — V. 88. — P. 1995–2002.
317. Walsy B.W. Effects of postmenopausal estrogen replacement of the
contractions and metabolism of plasma lipoproteins // New Engl. J.
Med. — 1191. — V. 325. — P. 1196–1204.
318. Whitehead M.I., Hillard T.C. The role and use of progestogens // Obstet.
Gynecol. — V. 75. — P. 59–76.
319. Whitehead M.I., Whitcrofts I.S., Hilard T.C. An atlas of the menopause. —
London, 1993. — P. 13–26.
320. Wingo P.A., Layde P.M., Lee N.C. et al. The risk of breast cancer in
postmenopausal women who have used estrogen replacement therapy //
Amer. Assoc. — 1987. — V. 257. — P. 209–215.
321. Winkler U. Menopause, hormone replacement therapy and cardiovascular
diseas — a review of hemostaseological findings // J. Fibrinolysis. —
1992. — V. 6. — P. 5–10.
Для заметок
https://t.me/med1917
Для заметок
https://t.me/med1917
Для заметок
https://t.me/med1917
Научное издание
https://t.me/med1917
Аккер Людмила Валентиновна
Гальченко Анжелика Ивановна
ХИРУРГИЧЕСКАЯ МЕНОПАУЗА
Санитарно-эпидемиологическое заключение
№ 77.99.60.953.Д.000945.01.10 от 21.01.2010 г.
Подписано в печать 15.02.2014. Формат 60 u 90/16.
Бумага офсетная. Гарнитура Newton. Печать офсетная.
Объем 10,5 печ. л. Тираж 1500 экз. Заказ №
ООО «Издательство «Медицинское информационное агентство»
119048, Москва, ул. Усачева, д. 62, стр. 1, оф. 6
Тел./факс: (499) 245-45-55
E-mail: miapubl@mail.ru
http://www.medagency.ru
Интернет-магазин: www.medkniga.ru
Книга почтой на Украине: а/я 4539, г. Винница, 21037
Отпечатано в ОАО «Тверской полиграфический комбинат»
E-mail: maxbooks@svitonline.com
Телефоны: +380688347389, 8 (0432) 660510
170024, г. Тверь, проспект Ленина, д. 5
Соседние файлы в папке @xirurgi_2025